Three ways in
- How it works — the mechanism: activating named keystone butyrate-producers, and why that matters for the gut-brain axis. Read →
- The evidence — what's shown today (ex-vivo, published literature) versus what's planned (the clinical program), with the numbers and the hedges intact. Read →
- Quality & manufacturing — extraction, specification, and the regulatory pathway — the answers a formulator needs for due diligence. Read →
For the IP and defensibility story — patents, the EPO opinion, and the trade-secret layer — see /ip.